PD-Rx Pharmaceuticals, Inc. (PDRX)

OTCMKTS · Delayed Price · Currency is USD
3.330
0.00 (0.00%)
At close: Mar 4, 2026
33.20%
Market Cap 5.48M
Revenue (ttm) 18.35M
Net Income (ttm) -257.52K
Shares Out 1.64M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 500
Average Volume 1,448
Open 3.330
Previous Close n/a
Day's Range 3.330 - 3.330
52-Week Range 2.410 - 3.330
Beta 1,706,352.39
RSI 58.29
Earnings Date Nov 20, 2025

About PD-Rx Pharmaceuticals

PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States. The company offers prepackaged medications, such as creams, ointments, ophthalmics, otics, liquids, and suspension products. It also provides packaging services. In addition, the company offers a dispensing platform, a manual dispensing system that provides 10 recordkeeping labels to match the 10 bottle trays as a handling package; and PD-Rx Net, a web-based application designed to trac... [Read more]

Sector Healthcare
Founded 1986
Employees 28
Stock Exchange OTCMKTS
Ticker Symbol PDRX
Full Company Profile

Financial Performance

In fiscal year 2025, PD-Rx Pharmaceuticals's revenue was $18.35 million, a decrease of -3.15% compared to the previous year's $18.95 million. Losses were -$257,523, -65.82% less than in 2024.

Financial Statements

News

There is no news available yet.